Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
TargetMol | Molecular Docking

Target Fishing

Decoding molecular mechanisms.Target identification powered by data.

Inquiry
Advantages of Target Fishing
TargetMol | Copyrighted software
Various drug screening models
Provides drug screening models for various enzymatic/GPCR targets
TargetMol | Comprehensive Analysis
Adequate screening resources
Thousands of screened compound libraries and twenty million diverse drug-like compounds
TargetMol | Visualized Binding Modes
High-throughput screening instrument
Meets large-scale screening needs and can carry out screening experiments with various plate types.
TargetMol | Experienced Team
High-quality service level
Customize drug discovery plans that meet budget requirements
DARTS (DrugAffinity Responsive Target stability)

DARTS is an innovative technique developed based on the principle that the binding of small-molecule drugs to theirtarget proteins reduces the target protein's susceptibility to proteolytic degradation. This technique does not requiredrug modification or depend on drug activity, making it widely applicable for drug screening and target identification.

In DARTS experiments, specific methods are reguired to assess the effects of proteolysis, Commonly used techniguesinclude SDS-PAGE and gel staining methods such as Coomassie Brilliant Blue staining. Additionally, protein two-dimensional electrophoresis (2D-PAGE), gel-based or gel-free mass spectrometry (LC-MS/MS), and other methods canalso be utilized for detection, By comparing the significant differences in proteolysis between the drug-treated andcontrol groups, potential drug targets can be identified forfurther experimental validation.

Kinase Screening

Kinases include protein kinases, phosphatases, and phosphodiesterases. Among the more than 500 kinases encoded in the human genome, protein kinases represent the largest class. They covalently transfer phosphate groups to other proteins, resulting in protein phosphorylation and altered activity, playing widespread and critical roles in cellular signaling and various complex biological processes.

Dysregulation of protein kinase expression or function can lead to cancer and other diseases. Among well-established drug targets, protein kinases have become a highly important class for drug discovery and screening. To date, approximately 280 kinase inhibitor drugs have been approved, with receptor tyrosine kinase (RTK) inhibitors being the most prominent.

TargetMol has extensive experience in kinase-targeted drug screening, discovery, and development.

Kinase Screening

Protein kinases are one of the most important drug targets in the field of drugdiscovery. Dysregulation of kinase functions is closely associated with the onsetand progression of many diseases, involving various human cell signalingpathways. Kinases exert their effects by phosphorylating specific downstreamsubstrate proteins.Abnormal regulation of kinase-mediated signaling pathways isa key cause of major human pathological conditions, such as cancer, autoimmunediseases, cardiovascular diseases, neurodegenerative diseases, and metabolicdisorders. Currently, more than 500 kinases have been identified, categorized intoten familieS: TK, STE,TKL,AGC, CMGC, CAMK, RGC,CKl,Atypical, and Other.